HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-Ever gene therapy injected directly into hearts of patients
Disease control Recruiting nowThis is the first study in people to test a new gene therapy called TN-201 for a genetic heart condition called hypertrophic cardiomyopathy (HCM). It will involve up to 30 adults who have HCM caused by a specific gene mutation (MYBPC3). The main goals are to find a safe dose and …
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE1, PHASE2 • Sponsor: Tenaya Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Heart drug safety under microscope in long-term study
Disease control Recruiting nowThis study is checking the long-term safety of the experimental drug HRS-1893 in people with hypertrophic cardiomyopathy, a condition where the heart muscle thickens. It will follow 300 patients who have already taken this medication in previous studies. Researchers will monitor …
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Heart drug put to the test in major Real-World study
Disease control Recruiting nowThis study aims to see how well the medication mavacamten works for Chinese adults who have a condition where their heart muscle is abnormally thick, making it harder for the heart to pump blood. It will follow 500 patients in real-world doctor's offices, not a controlled lab set…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Can exercise ease this heart condition? new trial investigates
Symptom relief Recruiting nowThis study is testing whether a 24-week program of moderate exercise can improve symptoms and heart function in people with hypertrophic cardiomyopathy (HCM). About 70 participants will be randomly assigned to either follow the exercise program or continue with their usual physic…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Major heart study launches to track 1000 patients across austria
Knowledge-focused Recruiting nowThis study is creating a national registry to collect detailed health information from 1000 adults in Austria diagnosed with hypertrophic cardiomyopathy (HCM), a serious heart condition. The goal is to better understand how the disease progresses, identify patterns, and ultimatel…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Tracking babies born to moms on heart drug
Knowledge-focused Recruiting nowThis study aims to understand the safety of the heart medication mavacamten during pregnancy and breastfeeding. Researchers will follow about 20 people who took the drug while pregnant or nursing, tracking the health of both the parent and baby for up to a year after birth. This …
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
Hospital launches major effort to map the mysteries of rare diseases
Knowledge-focused Recruiting nowThis study aims to create a single, large registry to collect information on many different rare diseases. It will enroll about 380 patients already being treated at the Hospital Italiano de Buenos Aires who have one of the listed rare conditions. The goal is to gather data to be…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC